Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.75 CHF | -0.71% |
|
-0.24% | +18.27% |
Sales 2024 * | 182M 204M | Sales 2025 * | 206M 231M | Capitalization | 504M 566M |
---|---|---|---|---|---|
Net income 2024 * | 23M 25.83M | Net income 2025 * | 35M 39.31M | EV / Sales 2024 * | 3.09 x |
Net Debt 2024 * | 57.88M 65.01M | Net Debt 2025 * | 12.51M 14.05M | EV / Sales 2025 * | 2.51 x |
P/E ratio 2024 * |
20.9
x | P/E ratio 2025 * |
17.7
x | Employees | 147 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.61% |
Latest transcript on Basilea Pharmaceutica AG
1 day | -0.71% | ||
1 week | -0.24% | ||
Current month | -4.46% | ||
1 month | -3.13% | ||
3 months | +16.30% | ||
6 months | +18.10% | ||
Current year | +18.27% |
![Extreme 41.1](/images/extremecours_fleche.png)
![Extreme 41.1](/images/extremecours_fleche.png)
![Extreme 32](/images/extremecours_fleche.png)
![Extreme 32](/images/extremecours_fleche.png)
![Extreme 29.55](/images/extremecours_fleche.png)
![Extreme 29.28](/images/extremecours_fleche.png)
![Extreme 29.28](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 59 | 14-08-31 |
Adesh Kaul
DFI | Director of Finance/CFO | 50 | 08-12-31 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 60 | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicole Onetto
BRD | Director/Board Member | 71 | 17-04-26 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-12-31 |
Director/Board Member | 69 | 13-04-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 775 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 32 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 41.75 | -0.71% | 10,710 |
24-06-13 | 42.05 | +0.12% | 9,476 |
24-06-12 | 42 | +1.20% | 14,171 |
24-06-11 | 41.5 | -0.84% | 26,984 |
24-06-10 | 41.85 | -0.83% | 19,462 |
Delayed Quote Swiss Exchange, June 14, 2024 at 11:30 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.27% | 568M | |
+40.80% | 55.66B | |
-8.05% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+10.69% | 26.29B | |
-16.21% | 20.25B | |
+31.00% | 12.76B | |
+28.51% | 12.18B | |
-1.67% | 12.12B |
- Stock Market
- Equities
- BSLN Stock